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Objectives: Swallowing disorders may be associated with adverse 
clinical outcomes in patients following invasive mechanical ventila-
tion. We investigated the incidence of dysphagia, its time course, 
and association with clinically relevant outcomes in extubated 
critically ill patients.
Design: Prospective observational trial with systematic dysphagia 
screening and follow-up until 90 days or death.
Settings: ICU of a tertiary care academic center.
Patients: One thousand three-hundred four admissions of mixed 
adult ICU patients (median age, 66.0 yr [interquartile range, 
54.0–74.0]; Acute Physiology and Chronic Health Evaluation-II 
score, 19.0 [interquartile range, 14.0–24.0]) were screened for 
postextubation dysphagia. Primary ICU admissions (n = 933) 
were analyzed and followed up until 90 days or death. Patients 
from an independent academic center served as confirmatory 
cohort (n = 220).
Interventions: Bedside screening for dysphagia was performed 
within 3 hours after extubation by trained ICU nurses. Positive 
screening triggered confirmatory specialist bedside swallowing 
examinations and follow-up until hospital discharge.
Measurements and Main Results: Dysphagia screening was posi-
tive in 12.4% (n = 116/933) after extubation (18.3% of emer-
gency and 4.9% of elective patients) and confirmed by specialists 
within 24 hours from positive screening in 87.3% (n = 96/110, 
n = 6 missing data). The dysphagia incidence at ICU discharge 
was 10.3% (n = 96/933) of which 60.4% (n = 58/96) remained 
positive until hospital discharge. Days on feeding tube, length of 
mechanical ventilation and ICU/hospital stay, and hospital mortal-
ity were higher in patients with dysphagia (all p < 0.001). The 
univariate hazard ratio for 90-day mortality for dysphagia was 3.74 
(95% CI, 2.01–6.95; p < 0.001). After adjustment for disease 
severity and length of mechanical ventilation, dysphagia remained 
an independent predictor for 28-day and 90-day mortality (excess 
90-d mortality 9.2%).
Conclusions: Dysphagia after extubation was common in ICU 
patients, sustained until hospital discharge in the majority of 
affected patients, and was an independent predictor of death. 
Dysphagia after mechanical ventilation may be an overlooked 
problem. Studies on underlying causes and therapeutic interven-
tions seem warranted. (Crit Care Med 2017; XX:00–00)
Key Words: aspiration; deglutition disorder; muscular failure; 
sepsis; swallowing disorder
Swallowing disorders in critically ill patients may cause aspiration pneumonia, necessitate tracheostomy, and delay reinstitution of oral feeding. Previous reports sug-
gest that presence of oropharyngeal dysphagia may impede 
recovery from critical illness (1–3), induce malnutrition/
cachexia (4, 5), and prolong mechanical ventilation (MV) 
and ICU/hospital stay (6). In the general medical population, 
dysphagia is considered to impose a considerable burden on 
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public healthcare systems and was estimated to account for 
as much as 10 billion dollars of healthcare costs in the United 
States annually (7, 8).
The overall incidence of dysphagia in critically ill patients 
following MV is largely unknown. Previously, most retrospec-
tive studies in smaller heterogeneous cohorts or selected high-
risk populations (e.g., in patients after diagnosed aspiration) 
without systematic screening have reported highly variable 
(3–62%) incidence (1, 2, 9–16). In addition, different timing of 
screening and lack of follow-up add to an incomplete under-
standing of the potential impact of dysphagia on the clinical 
course of ICU survivors (1, 2, 7, 9, 17). Given the fact that long-
term impairment often results from critical illness (18–21), 
data on the incidence, evolution, and impact of dysphagia on 
clinical outcomes seem warranted (1, 2, 9).
The etiology of dysphagia after MV is unknown and con-
sidered multifactorial. Neurologic disease including neuro-
muscular weakness (e.g., ICU-acquired weakness), altered 
consciousness, reduced sensorium and motor response, use 
of sedative/analgesic drugs, direct oropharyngeal or laryngeal 
trauma (e.g., tube induced) (22, 23), increased gastrointestinal 
reflux, and prolonged MV may all contribute to development 
of dysphagia (1, 2, 9, 24–31).
Systematic screening for dysphagia in the ICU is uncom-
mon, and dysphagia screening methods mostly derive from 
stroke patients. Proposed diagnostic approaches for dysphagia 
include the bedside water swallow test (WST) (32), the fiber-
optic endoscopic evaluation of swallowing (FEES), and video-
fluoroscopic swallowing studies (VFSS) (1, 2, 9, 32–36). VFSS 
and FEES are invasive, time-consuming, and complex proce-
dures that require substantial resources (including transfer to 
a radiology suite in VFSS) and may not be readily available 
in most ICUs. Bedside WST examinations make systematic 
screening of dysphagia feasible in recently extubated critically 
ill patients (1, 9, 32).
We prospectively studied the incidence and evolution of 
dysphagia after MV and its association with clinical outcomes 
in a large cohort of adult multidisciplinary ICU patients.
MATERIALS AND METHODS
Trial Design and Patients, Inclusion/Exclusion 
Criteria
A prospective observational trial with systematic dysphagia 
screening (Dysphagia in Mechanically Ventilated ICU Patients 
[DYnAMICS]) was performed from April 2015 until October 
2015 in a 900+ bed tertiary care academic medical center (Insel-
spital, Bern University Hospital, Switzerland). In this center, the 
Department of Intensive Care Medicine is the sole provider of 
intensive care medicine for adults. A second tertiary care aca-
demic center (Kuopio University Hospital, Finland) and its sole 
provider of intensive care medicine for adults (Department of 
Anesthesiology and Intensive Care; inclusion from October 
2015 to December 2015) served as confirmatory cohort regard-
ing incidence. All consecutive patients extubated/decannulated 
after MV were included. Prerequisites for extubation were 
stable gas exchange and hemodynamics on moderate pressure 
support and positive end-expiratory pressure, responsive to 
commands and presumably able to protect the airway. Initial 
bedside screening for dysphagia was performed within 3 hours 
of extubation unless any of the following exclusion criteria were 
met: 1) patients dying/on comfort therapy and 2) patients with 
recent esophageal injury and/or surgery (Fig. 1). Patients were 
followed up until 90 days, or death. The trial was performed 
in accordance with the “Declaration of Helsinki” and approved 
by the Kantonale Ethikkommission KEK, Bern, Switzerland, Nr. 
314/2014 and Research Ethics Committee of the Northern Savo 
Hospital district, Finland.
Bedside Screening for Dysphagia, Confirmatory 
Examinations, and Diagnostic Criteria
Following physician-supervised repetitive training of ICU 
nurses, systematic standardized bedside dysphagia screening 
was performed within 3 hours of extubation. In brief, patients 
were checked for exclusion criteria and readiness to attempt 
swallowing (with one reassessment performed after 3 hr, if 
necessary; Fig. E1, Supplemental Digital Content 1, http://
links.lww.com/CCM/C952). WSTs consisted of consecutive 
swallowing of three teaspoons of water (room temperature) 
followed by drinking half a glass (about 100 mL) of water (as 
suggested elsewhere [32, 37]). Coughing, choking, breathless-
ness, wet or gurgly voice, or any other symptom (e.g., water 
leaking out of mouth) suggestive of a swallowing disorder in 
any WST step were considered as WST failure. Failure in two 
screenings triggered examination by a dysphagia specialist 
(physiotherapist or speech language therapist [SLT]). WSTs 
could be replaced by specialist examinations on clinical indi-
cations (e.g., obvious severe dysphagia, Fig. 1). Dysphagia in 
screening is referred to as “screening positive,” and dysphagia 
confirmed by specialists’ examination as “confirmed dyspha-
gia.” In screening positive patients, a nil per os status (except 
for feeding via gastric tube; Fig. E1, Supplemental Digital 
Content 1, http://links.lww.com/CCM/C952) was prescribed 
until dysphagia specialist examinations were performed (≤ 
24 hr). If ICU discharge occurred within 24 hours from posi-
tive screening, only one specialist assessment was performed 
and considered to represent the ICU discharge status. Patients 
with confirmed dysphagia were followed up (physiotherapist/
SLT), and a final specialist assessment was performed less than 
or equal to 48 hours before hospital discharge. Dysphagia was 
treated by physiotherapist/SLT based on respective previous 
clinical assessments and the general principle of functional 
dysphagia therapy using 1) compensatory treatment proce-
dures including postural changes (with mobilization, head 
and upright positioning), 2) adaptive measures including 
dietary texture modifications (liquid, nectar, pudding) and 
use of auxillary tools such as straw/spoon/glas, and 3) func-
tional exercises for motor and sensomotor recovery with 
tongue and lip exercises, as suggested elsewhere (38). Func-
tional outcomes and discharge destinations were recorded 
(Fig. E1, Supplemental Digital Content 1, http://links.lww.
com/CCM/C952).
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Assessment of Disease Severity, and ICU  
Resource Use
For assessment of disease severity, baseline Acute Physiology 
and Chronic Health Evaluation (APACHE)-II scores (39) and 
Simplified Acute Physiology Score (SAPS)-II scores (40) were 
recorded. ICU resource use was assessed by analysis of the sum 
of Therapeutic Intervention Scoring System (TISS)-28 points 
(recorded once per shift over ICU stay) (41, 42). Total days on 
invasive MV, need for feeding tube, days on antibiotics/antimi-
crobials, days on vasopressors, and need for renal replacement 
therapy were recorded. Dysphagia severity was assessed using 
the following scoring systems: Bogenhausen Dysphagia Scores 
(BODS)-1/-2 and BODS sum score (impairment in saliva 
swallowing, oral intake) (38), National Outcomes Measure-
ment System (NOMS): American Speech Language Hearing 
Association (1998–2008) and 
Dysphagia Outcome Sever-
ity Scale (DOSS) (therapeutic 
dependency/diet restrictions) 
(43). At ICU and hospital dis-
charge, the Functional Inde-
pendence Measure (44) and 
Medical Research Council sum 
score (45) less than 48 (yes/no; 
i.e., ICU-acquired weakness 
present or not) was recorded.
Statistical Analyses
Data were checked for normal 
distribution (Shapiro-Wilk 
test) with log transformation 
performed in an effort to reach 
normal distribution when indi-
cated. Data are given as medi-
ans and 25–75th interquartile 
ranges (IQRs) or means ± sds, 
as indicated. For between-
group comparisons, rank-sum 
test (Mann-Whitney U) was 
used. For categorical data, 
Fisher exact test was used. Uni-
variate followed by multivari-
ate models including relevant 
clinical variables were used. 
Multivariate logistic regression 
was used to identify potential 
predisposing factors leading 
to dysphagia. For assessment 
of mortality prediction, Cox 
proportional hazards regres-
sion models were calculated. 
Patients were censored at time 
of loss to follow-up or at days 
28 and 90, respectively. Log-
rank p values (survival curves) 
and hazard ratios (HR) are 
given. Evolution of dysphagia severity was assessed by analysis 
of variance for repeated measures. Significance was assigned 
when the p value was less than 0.05. Statistical analysis was per-
formed using MedCalc 16.4.3 Software (MedCalc, Mariakerke, 
Belgium).
RESULTS
Baseline Characterization of Study Cohort
A total of 1,304 admissions with 1,200 patients with first 
time ICU admission were assessed, and n = 933 individu-
als (56% emergency vs 44% elective patients, 61% postop-
erative patients, Table 1) were analyzed (Fig. 1). Emergency 
patients were younger and more severely ill (Table 1). Fifteen 
patients (1.6%) were decannulated from a tracheal tube. For 
Figure 1. Trial flow chart. 
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characteristics of the confirmatory cohort (n = 220), see sup-
plement (Supplemental Digital Content 1, http://links.lww.
com/CCM/C952).
Dysphagia Incidence, Results From Specialist 
Examinations, and Confirmatory Data
In total, 116 of 933 patients (12.4%) were screening positive 
for dysphagia (Fig. 1; 18.3% of emergency and 4.9% of elective 
patients). Specialist examinations (performed at median 0.76 
(IQR, 0.37–1.0) days from positive screening) confirmed per-
sisting dysphagia in 87.3% of cases (positive predictive value; 
n = 96/110, 10.4% of total population; missing data n = 6). Of 
patients discharged from the ICU with confirmed dysphagia, 
90 patients survived the hospital stay and n = 58 of 90 (64.4%) 
did not recover from dysphagia until hospital discharge (Fig. 1). 
In the independent cohort (n = 220), confirmed dysphagia was 
noted in 11.4% following extubation (n = 25/218; 29.1% emer-
gency vs 1.4% elective subgroups; n = 2 missing data).
Underlying Disease Characteristics in Dysphagia 
Patients
When grouped for APACHE-IV admission diagnostic groups, 
75% of patients had a cardiovascular (n = 556/933; 59.6%) or 
a neurologic (n = 147/933; 15.8%) diagnosis (Table 1). At ICU 
discharge (n = 96), dysphagia was most common in patients 
admitted for neurologic disease (incidence rate 41%; n = 39), 
cardiovascular disease (29.2%; n = 28), trauma (15%; n = 
14), and respiratory disease (6.3%; n = 6). When age, gender, 
baseline disease severity (APACHE-II or SAPS-II), admission 
status (elective vs emergency), admission diagnosis (neuro-
logic vs nonneurologic), and length of MV were included in 
multivariate logistic regression models, APACHE-II score 
(odds ratio [OR], 1.05; 95% CI, 1.01–1.09), admission status 
(OR for emergency admission, 2.60; 95% CI, 1.47–4.59), and 
admission diagnosis (OR for neurologic disease, 3.46; 95% 
CI, 2.17–5.52), but not length of MV, were associated with a 
screening positive status (all p < 0.01).
TABLE 1. Baseline Demographics of Extubated ICU Patients
 Total Groups
Variables All, n = 933
Dysphagia Screening 
Positive, n = 116
Dysphagia Screening 
Negative, n = 817 p
Age (yr), median (IQR) 65 (54–73.3) 64.5 (49.5–77.0) 65.0 (55.0–73.0) 0.83
Gender (male), n (%) 666 (71) 80 (69) 586 (72) 0.58
Weight (kg), median (IQR) 80.0 (70.0–90.0) 76.0 (69.8–86.0) 80.0 (70.0–90.0) 0.07
Body mass index, median (IQR) 26.2 (23.7–29.4) 25.7 (23.5–27.8) 26.3 (23.7–29.3) 0.07
APACHE-II score, median (IQR) 17 (13–23) 21 (17–25) 17 (13–22) < 0.001
Simplified Acute Physiology Score-II score, 
median (IQR)
36 (28–46) 42.5 (34–55.5) 35 (28–45) < 0.001
APACHE-IV admission diagnostic groups, 
n (%)
    
 Cardiovascular 556 (59.6) 34 (29.3) 522 (63.9) < 0.001
 Respiratory 52 (5.6) 6 (5.2) 46 (5.6) 1.0
 Gastrointestinal 56 (6.0) 5 (4.3) 51 (6.2) 0.53
 Neurologic 147 (15.8) 47 (40.5) 100 (12.2) < 0.001
 Trauma 71 (7.6) 17 (14.7) 54 (6.6) 0.005
 Metabolic 2 (0.2) 0 (0) 2 (0.3)
 Hematologic 4 (0.4) 2 (1.7) 2 (0.3) 0.08
 Urological 5 (0.5) 1 (0.9) 4 (0.5) 0.49
 Diverse 31 (3.3) 2 (1.7) 29 (3.5) 0.41
 Intoxication 9 (1.0) 2 (1.7) 7 (0.9) 0.31
Postoperative, n (%) 569 (61) 44 (38) 525 (64) < 0.001
Emergency admission, n (%) 525 (56) 96 (83) 429 (53) < 0.001
APACHE = Acute Physiology and Chronic Health Evaluation, IQR = interquartile range.
Total group; data for emergency and elective subgroups are given in Table E3 (Supplemental Digital Content 1, http://links.lww.com/CCM/C952). Mann-
Whitney U or Fisher exact test. Acute Physiology and Chronic Health Evaluation-II and Simplified Acute Physiology Score-II scores at ICU admission are given.
Boldface values indicate statistically significant results.
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Evolution of Dysphagia Severity and Recovery From 
Dysphagia
Over the ICU stay, dysphagia disease severity scores (BODS, 
NOMS, DOSS) remained unchanged (except in 14 patients 
recovering from dysphagia until ICU discharge). Dysphagia 
severity declined until hospital discharge (p < 0.02 for BODS, 
DOSS, NOMS scores in patients with complete datasets) (Table 
E1, Supplemental Digital Content 1, http://links.lww.com/CCM/
C952). At hospital discharge, 33% of patients (n = 32/96) with 
confirmed dysphagia at ICU discharge had recovered. The recov-
ery rate from dysphagia was highest in the cardiovascular diag-
nostic group (54%; n = 15/28) and lowest in neurologic patients 
(18%; n = 7/39). The OR for nonrecovery from dysphagia in 
neurologic (vs cardiovascular) patients was 5.27 (95% CI, 1.75–
15.92; p = 0.003), and the OR for nonrecovery in emergency ver-
sus elective patients was 6.18 (95% CI, 1.92–19.89; p = 0.002).
Resource Use, Length of Stay, Readmission Rates, 
and Clinical Outcomes
Patients with dysphagia had longer invasive MV (all p ≤ 0.002), use 
of feeding tube (all p < 0.001), antibiotic/antimicrobial therapy 
(p ≤ 0.04), and more need for adrenaline (p ≤ 0.008) (Table 2). 
Overall resource use (cumulative TISS-28 points, all p < 0.001), 
ICU and hospital length of stay (all p ≤ 0.008), and all-cause hos-
pital mortality rate (all p ≤ 0.02) were higher in screening posi-
tive patients (Table 2). In respective patients, all-cause 28-day and 
90-day mortality was increased by 6.6% and 9.2%, respectively 
(Table 2), with more frequent reintubations (n = 34/116; 29.3% 
vs 33/817; 4.0%; p < 0.001) and more ICU readmissions (n = 
20/116; 17% vs 61/756; 7.5%; p < 0.001) observed. Patients with 
dysphagia were less likely to be discharged home (with/without 
receiving home care) (13.8% vs 29.0%; OR, 0.40 [95% CI, 0.23–
0.69]; p = 0.001) and more likely discharged to other hospitals 
(including rehabilitation hospitals) (77.9% vs 67.3%; OR, 1.71; 
95% CI, 1.07–2.73; p = 0.03). Hospital readmission rates within 
14 days from hospital discharge in patients with versus without 
dysphagia did not differ (1.7% vs 0.9%; p = 0.4).
Association of Dysphagia With Clinical Outcomes
In univariate regression (Table 3), baseline disease severity 
(APACHE-II and SAPS-II scores, both p ≤ 0.001), admis-
sion status (i.e., emergency vs elective) (p = 0.002), days 
TABLE 2. Resource Use, Length of Stay, and Clinical Outcomes
 Total Groups
Variables All, n = 933
Dysphagia Screening 
Positive, n = 116
Dysphagia Screening 
Negative, n = 817 p
Days on invasive mechanical ventilation, median (IQR) 0.7 (0.5–1.3) 1.2 (0.6–3.3) 0.7 (0.5–1.1) < 0.001
Days on feeding tube, median (IQR) 0.6 (0.4–2.3) 4.5 (1.7–6.8) 0.6 (0.3–1.5] < 0.001
Days on nasogastric tube, median (IQR) 0.6 (0.4–2.0) 4.2 (1.6–6.4) 0.6 (0.3–1.4] < 0.001
Days on antibiotics, median (IQR) 1.0 (0.0–2.0) 1.0 (1.0–4.5) 1.0 (0.0–2.0) 0.04
Days on antimicrobials, median (IQR) 1.0 (0.0–2.0) 1.0 (1.0–4.5) 1.0 (0.0–2.0) 0.04
Days on vasopressors, median (IQR) 0 (0–0.5) 0.005 (0–0.8) 0 (0–0.5) 0.35
Days on adrenaline, median (IQR), median (IQR) 0 (0–0) 0 (0–0.1) 0 (0–0) 0.008
Days on noradrenaline, median (IQR) 0 (0–0.3) 0 (0–0.5) 0 (0–0.3) 0.47
Patients on vasopressors, n (%) 494 (52.9) 64 (55.2) 431 (52.8) 0.7
Patients on renal replacement therapy, n (%) 47 (5.0) 12 (10.3) 35 (4.3) 0.01
Cumulative Therapeutic Intervention Scoring System-28 
points, median (IQR)
124 (98–260) 344 (183–758) 119 (94–223) < 0.001
ICU LOS total days, median (IQR) 1.0 (0.8–2.2) 2.9 (1.6–6.0) 0.9 (0.8–1.8) < 0.001
ICU LOS until extubation, median (IQR) 0.5 (0.3–1.2) 1.2 (0.4–3.3) 0.5 (0.3–0.9) < 0.001
ICU LOS after extubation, median (IQR) 0.5 (0.3–0.9) 1.1 (0.7–2.5) 0.5 (0.3–0.8) < 0.001
Hospital LOS (d), median (IQR) 11.0 (8.0–17.6) 17.9 (7.8–24.9) 10.2 (8.0–15.8) < 0.001
All-cause ICU mortality, n (%) 8 (0.9) 2 (1.7) 6 (0.7) 0.3
All-cause hospital mortality, n (%) 22 (2.4) 9 (7.8) 13 (1.6) 0.001
All-cause 28-day mortality, n (%) 35 (3.8) 11 (9.5) 24 (2.9) 0.002
All-cause 90-day mortality, n (%) 45 (4.8) 15 (12.9) 30 (3.7) < 0.001
IQR = interquartile range, LOS= length of stay.
Total group; data for emergency and elective subgroups is given in Table E4 (Supplemental Digital Content 1, http://links.lww.com/CCM/C952). Mann-Whitney 
U or Fisher exact test. Cumulative Therapeutic Intervention Scoring System-28 points are given for total ICU stay.
Boldface values indicate statistically significant results.
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on MV (p = 0.008), and dysphagia status (p < 0.001) were 
associated with 28-day mortality. The univariate hazard 
for 28-day mortality was increased in patients with dys-
phagia (vs nonaffected patients; Table 3). In multivariate 
regression (Table 3), dysphagia was independently associ-
ated with 28-day mortality (HR, 2.67; 95% CI, 1.29–5.51; 
p = 0.008) after adjustment for age, gender, disease sever-
ity (APACHE-II score), and length of MV. When SAPS-II 
instead of APACHE-II scores, or admission status (emer-
gency vs elective), or admission for neurologic/ nonneu-
rologic disease (APACHE-IV admission category) was 
included in the model, dysphagia remained an indepen-
dent predictor (not shown). The univariate HR for 90-day 
mortality was increased in the dysphagia group also (Table 
E2, Supplemental Digital Content 1, http://links.lww.com/
CCM/C952). After adjustment, dysphagia (HR, 2.95; 95% 
CI, 1.57–5.53; p < 0.001) and APACHE-II score remained 
independent predictors of 90-day mortality (Table E2, Sup-
plemental Digital Content 1, http://links.lww.com/CCM/
C952; survival estimates following ICU admission [Fig. 2] 
and following extubation [Fig. E2, Supplemental Digital 
Content 1, http://links.lww.com/CCM/C952] are given).
DISCUSSION
Our main finding was a high incidence of dysphagia after extu-
bation, its persistence until hospital discharge, and its associa-
tion with clinically relevant adverse outcomes. The prospective 
large-scale approach applying systematic screening in a gen-
eral ICU population may be regarded a strength of our analy-
sis, and the high incidence was confirmed in an independent 
sample of comparable patients from another institution. Use 
of simple structured standardized bedside dysphagia screen-
ing by trained ICU nurses enabled systematic testing of all 
extubated patients, with the vast majority of screening posi-
tive cases being confirmed in prompt specialist examinations. 
Overall, the incidence was likely underestimated due to exclu-
sion of 65 patients leaving our ICU alive with tracheostomy 
(no extubation/decannulation).
We observed that patients with postextubation dysphagia had 
longer tube feeding and MV, more antimicrobial drugs and ICU 
resources, increased ICU and hospital length of stay, and increased 
intrahospital-, 28-day-, and 90-day mortality. After adjust-
ment for age, gender, length of MV, and baseline disease sever-
ity (APACHE-II or SAPS-II), or neurologic versus nonneurologic 
disease, dysphagia remained an independent predictor for 28-day 
TABLE 3. Univariate and Multivariate Regression Models (28-d Mortality)
 
Univariate Model (28 d Following ICU 
 Admission)
Multivariate Model (28 d Following ICU 
Admission)
Variables Hazard Ratio (95% CI) p Wald Hazard Ratio (95% CI) p Wald
Age (per 1 yr increase) 1.02 (0.99–1.05) 0.09 2.9 1.01 (0.99–1.04) 0.35 0.88
Gender (female) 1.51 (0.76–3.004) 0.24 1.4 1.27 (0.64–2.54) 0.5 0.46
Weight (per 1 kg increase) 0.98 (0.96–1.002) 0.07 3.3 — — —
Body mass index (per 1 step 
increase)
0.97 (0.90–1.05) 0.46 0.6 — — —
Acute Physiology and Chronic Health 
Evaluation-II score (per 1 increase)
1.09 (1.05–1.14) < 0.001 15.6 1.07 (1.02–1.13) 0.005 8
Simplified Acute Physiology Score-II 
score (per 1 increase)
1.04 (1.02–1.06) < 0.001 12.7 — — —
Cumulative Therapeutic Intervention 
Scoring System-28 points (per 10 
increase)
1.004 (0.99–1.01) 0.11 2.6 — — —
Admission status (emergency group) 3.90 (1.62–9.40) 0.002 9.2 — — —
Dysphagia positivity on ICU 
( dysphagia group)
3.37 (1.65–6.87) < 0.001 11.1 2.67 (1.29–5.51) 0.008 7
Days on invasive mechanical 
 ventilation (per 1 increase)
1.05 (1.01–1.09) 0.008 7 1.05 (1.01–1.10) 0.03 4.6
Days on renal replacement therapy 
(per 1 increase)
1.03 (0.92–1.15) 0.65 0.2 — — —
Days on vasopressors (per 1 increase) 0.99 (0.87–1.13) 0.83 0.05 — — —
Days on antimicrobials (per 1 increase) 0.90 (0.78–1.04) 0.16 2 — — —
Days on antibiotics (per 1 increase) 0.89 (0.77–1.04) 0.14 2.2 — — —
Hazard ratios for (co-) variates for ICU patients after mechanical ventilation. Acute Physiology and Chronic Health Evaluation-II and Simplified Acute Physiology 
Score-II score at ICU admission. Overall model fitness: p < 0.001, χ2  = 24.1.
Boldface values indicate statistically significant results. Dashes indicate data not included in model.
Copyright © 2017 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Clinical Investigation
Critical Care Medicine www.ccmjournal.org 7
and 90-day mortality. However, due to the observational nature of 
the trial, no cause-effect relationships can be concluded on.
Several limitations of our analysis deserve discussion. First, 
we present observations rather than cause-effect relationships. 
Hence, potential risk factors for 
dysphagia can be considered, 
but no conclusions on mecha-
nisms can be made. Second, all 
swallowing examinations, even 
when performed by dysphagia 
specialists, have problems with 
sensitivity/specificity, and there 
are no universally accepted 
bedside screening tools for dys-
phagia. Ideally, confirmation of 
dysphagia in screening positive 
individuals using instrumental 
assessment with FEES or VFSS 
would have allowed better 
specificity. We decided against 
the use of these confirmatory 
methods on logistic reasons, for 
example, transport to radiology 
suite for VFSS and availability 
of trained operators for FEES, 
and the relative invasiveness of 
both VFSS and FEES in recently 
extubated patients. Our choice 
to use the WST as a pragmatic 
bedside screening tool fol-
lowed by comprehensive spe-
cialist clinical examinations in 
screening positive cases thus is 
a compromise between feasibil-
ity and specificity. Several other 
investigators including a recent 
systematic review and meta-
analysis support the use of the 
WST in dysphagia screening (1, 
2, 9, 17, 32). Third, although 
about 90% of screening positive 
cases were confirmed to have 
dysphagia within a maximum 
time interval of 24 hours (posi-
tive predictive value 87.3%), the 
bedside screening procedure 
may have missed some dyspha-
gia patients. Since only patients 
who tested positive in screening 
were further evaluated for dys-
phagia, we cannot provide the 
negative predictive value of the 
bedside screening approach. 
Nevertheless, the strong asso-
ciation between clinically rel-
evant outcomes and dysphagia 
in this study supports the use of this pragmatic screening 
approach. Fourth, our statistical models include disease severity 
(scores) which potentially introduces some colinearity. Despite 
this, adjustment for disease severity was considered inevitable. 
Figure 2. Survival estimates for (A) all-cause 28-d and (B) all-cause 90-d mortality in dysphagia screening 
positive/negative patients (days after ICU admission). Log-rank p value both p < 0.001. Numbers at risk are 
indicated. Survival estimates (28 and 90 d) from extubation are given in Fig E2 (Supplemental Digital Content 
1, http://links.lww.com/CCM/C952).
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Further, one might argue that dysphagia could simply be a 
consequence of disease severity. Although disease severity was 
identified as a potential contributing factor to dysphagia in 
explorative analyses, dysphagia remained an independent pre-
dictor of all-cause, 28-day-, and 90-day mortality, when disease 
severity (APACHE-II or SAPS-II score), length of MV, admis-
sion status (e.g., emergency vs elective) (Table 3), and/or admis-
sion category (e.g., neurologic vs nonneurologic) were adjusted 
for. Thus, dysphagia may additionally worsen the outcome of 
affected patients. Although we are unaware of the exact causes 
for dysphagia, it seems tempting to speculate that future inter-
ventions for dysphagia might provide highest clinical benefits in 
patients with advanced disease severity. Fifth, the confirmatory 
cohort and the main cohort were somewhat different in regard 
to the distribution of emergency and elective admissions and 
underlying diagnoses (see supplement, Supplemental Digital 
Content 1, http://links.lww.com/CCM/C952). Nevertheless, the 
main findings were very similar indeed.
The increased number of neurologic patients with dyspha-
gia suggests that some cases can most likely be attributed to 
specific diseases, for example, stroke or injury, whereas in the 
majority, no specific cause could be identified. Similar pat-
terns of increased dysphagia incidence were found in the total 
cohort of patients and in those without neurologic reason for 
ICU admission after more than 2 days of intubation/MV (Fig. 
E3, Supplemental Digital Content 1, http://links.lww.com/
CCM/C952). This association between duration of intubation/
MV and subsequent development of dysphagia suggest that 
mechanical effects induced by the endotracheal tube should 
be evaluated as a potential cause of dysphagia in subsequent 
analyses. Other potential mechanisms include use of drugs 
that may interfere with swallowing, for example, analgesic/
sedative drugs. However, the overall short duration of MV in 
our trial suggests that exposure to these drugs was short, and 
hence unlikely to be a major contributor to dysphagia. Even 
about 5% of elective patients with rather short times of MV 
were dysphagia positive, which may help to gain insight to 
underlying causes.
CONCLUSIONS
In conclusion, prospective systematic screening for dysphagia 
after extubation followed by early specialist confirmation dem-
onstrated a high incidence of dysphagia. Patients with higher 
disease severity, emergency admission, and/or underlying neu-
rologic disease were at increased risk for dysphagia. Dyspha-
gia detected in the ICU persisted in the majority of affected 
patients throughout the hospital stay and was itself associated 
with increased morbidity and mortality. Dysphagia after MV 
thus seems an overlooked health problem that is associated 
with adverse clinical outcomes. Studies on underlying reasons 
and therapeutic interventions seem warranted.
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